# Home Federal Bancorp, Inc. of Louisiana: financial statements, quarterly

HFBL · Nasdaq · CIK 1500375 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/hfbl.md) · [Financials](/companies/hfbl/financials.md) · [Filings](/companies/hfbl/filings.md) · [Insiders](/companies/hfbl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hfbl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [2,790](/filings/0001140361-23-052977.md) | [3,177](/filings/0001140361-24-007011.md) | [3,486](/filings/0001140361-24-025939.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [310](/filings/0001140361-24-046395.md) | [(196)](/filings/0001140361-25-003986.md) | [176](/filings/0001140361-25-018629.md) | [186 d](/filings/0001140361-25-036293.md) | [(2.0)](/filings/0001140361-25-041344.md) | [187](/filings/0001140361-26-005040.md) | [207](/filings/0001140361-26-021225.md) | [374 d](/filings/0001140361-26-037680.md) | [418](/filings/0001140361-25-041344.md) | [438](/filings/0001140361-26-005040.md) | [318](/filings/0001140361-26-021225.md) | [437 d](/filings/0001140361-26-037680.md) |
| Net income | $k | [1,220](/filings/0001140361-24-046395.md) | [1,003](/filings/0001140361-25-003986.md) | [732](/filings/0001140361-25-018629.md) | [638 d](/filings/0001140361-25-036293.md) | [941](/filings/0001140361-25-041344.md) | [1,020](/filings/0001140361-26-005040.md) | [748](/filings/0001140361-26-021225.md) | [1,180 d](/filings/0001140361-26-037680.md) | [1,599](/filings/0001140361-25-041344.md) | [1,675](/filings/0001140361-26-005040.md) | [1,472](/filings/0001140361-26-021225.md) | [1,428 d](/filings/0001140361-26-037680.md) |
| Diluted EPS | $ per share | [0.39](/filings/0001140361-24-046395.md) | [0.33](/filings/0001140361-25-003986.md) | [0.24](/filings/0001140361-25-018629.md) | not reported | [0.31](/filings/0001140361-25-041344.md) | [0.33](/filings/0001140361-26-005040.md) | [0.24](/filings/0001140361-26-021225.md) | not reported | [0.52](/filings/0001140361-25-041344.md) | [0.54](/filings/0001140361-26-005040.md) | [0.48](/filings/0001140361-26-021225.md) | not reported |
| Basic EPS | $ per share | [0.40](/filings/0001140361-24-046395.md) | [0.33](/filings/0001140361-25-003986.md) | [0.24](/filings/0001140361-25-018629.md) | not reported | [0.31](/filings/0001140361-25-041344.md) | [0.33](/filings/0001140361-26-005040.md) | [0.24](/filings/0001140361-26-021225.md) | not reported | [0.53](/filings/0001140361-25-041344.md) | [0.55](/filings/0001140361-26-005040.md) | [0.49](/filings/0001140361-26-021225.md) | not reported |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [1.9](/filings/0001140361-25-036293.md) | not reported | not reported | not reported | [2.1](/filings/0001140361-26-037680.md) | not reported | not reported | not reported | [2.1](/filings/0001140361-26-037680.md) |
| Total assets | $m | [663](/filings/0001140361-23-052977.md) | [654](/filings/0001140361-24-007011.md) | [643](/filings/0001140361-24-025939.md) | [638](/filings/0001140361-25-036293.md) | [628](/filings/0001140361-24-046395.md) | [608](/filings/0001140361-25-003986.md) | [620](/filings/0001140361-25-018629.md) | [609](/filings/0001140361-26-037680.md) | [623](/filings/0001140361-25-041344.md) | [621](/filings/0001140361-26-005040.md) | [642](/filings/0001140361-26-021225.md) | [643](/filings/0001140361-26-037680.md) |
| Total liabilities | $m | [612](/filings/0001140361-23-052977.md) | [602](/filings/0001140361-24-007011.md) | [590](/filings/0001140361-24-025939.md) | [585](/filings/0001140361-25-036293.md) | [574](/filings/0001140361-24-046395.md) | [554](/filings/0001140361-25-003986.md) | [565](/filings/0001140361-25-018629.md) | [554](/filings/0001140361-26-037680.md) | [566](/filings/0001140361-25-041344.md) | [564](/filings/0001140361-26-005040.md) | [584](/filings/0001140361-26-021225.md) | [585](/filings/0001140361-26-037680.md) |
| Shareholders' equity | $m | [50.5](/filings/0001140361-25-003986.md) | [52.6](/filings/0001140361-25-018629.md) | [52.6](/filings/0001140361-25-018629.md) | [52.8](/filings/0001140361-26-037680.md) | [54.3](/filings/0001140361-26-005040.md) | [53.9](/filings/0001140361-26-021225.md) | [54.7](/filings/0001140361-26-021225.md) | [55.2](/filings/0001140361-26-037680.md) | [56.6](/filings/0001140361-26-005040.md) | [57.7](/filings/0001140361-26-021225.md) | [58.0](/filings/0001140361-26-021225.md) | [58.8](/filings/0001140361-26-037680.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [2,445](/filings/0001140361-24-046395.md) | [(2,635) d](/filings/0001140361-25-003986.md) | [650 d](/filings/0001140361-25-018629.md) | [1,858 d](/filings/0001140361-25-036293.md) | [871](/filings/0001140361-25-041344.md) | [2,590 d](/filings/0001140361-26-005040.md) | [991 d](/filings/0001140361-26-021225.md) | [1,020 d](/filings/0001140361-26-037680.md) | [2,776](/filings/0001140361-25-041344.md) | [2,855 d](/filings/0001140361-26-005040.md) | [(1,274) d](/filings/0001140361-26-021225.md) | [3,263 d](/filings/0001140361-26-037680.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $k | [392](/filings/0001140361-24-046395.md) | [392 d](/filings/0001140361-25-003986.md) | [393 d](/filings/0001140361-25-018629.md) | [392 d](/filings/0001140361-25-036293.md) | [409](/filings/0001140361-25-041344.md) | [407 d](/filings/0001140361-26-005040.md) | [407 d](/filings/0001140361-26-021225.md) | [406 d](/filings/0001140361-26-037680.md) | [415](/filings/0001140361-25-041344.md) | [418 d](/filings/0001140361-26-005040.md) | [417 d](/filings/0001140361-26-021225.md) | [413 d](/filings/0001140361-26-037680.md) |
| Share repurchases | $k | [0.0](/filings/0001140361-24-046395.md) | [30.0 d](/filings/0001140361-25-003986.md) | [9.0 d](/filings/0001140361-25-018629.md) | [448 d](/filings/0001140361-25-036293.md) | [182](/filings/0001140361-25-041344.md) | [152 d](/filings/0001140361-26-005040.md) | [182 d](/filings/0001140361-26-021225.md) | [557 d](/filings/0001140361-26-037680.md) | [279](/filings/0001140361-25-041344.md) | [1,991 d](/filings/0001140361-26-005040.md) | [623 d](/filings/0001140361-26-021225.md) | [440 d](/filings/0001140361-26-037680.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2012 (2011-09-30) | Q1 FY2013 (2012-09-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [2,859](/filings/0001065407-12-000466.md) | [2,594](/filings/0001065407-12-000466.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,030,594 at 2026-09-21, from the cover of the [10-K filed 2026-09-25](/filings/0001140361-26-037680.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.